We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$6.18B
Cap. Flow %
-1.26%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.23%
2 Technology 2.7%
3 Consumer Discretionary 1.66%
4 Financials 1.18%
5 Communication Services 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCE
10626
CALL
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$135K ﹤0.01%
+11,100
New +$132K
EGF
10627
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$135K ﹤0.01%
+14,106
New +$139K
HYB
10628
DELISTED
New America High Income Fund, Inc.
HYB
$135K ﹤0.01%
20,228
-20,715
-51% -$137K
SCU
10629
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$134K ﹤0.01%
15,201
-8,650
-36% -$75.1K
BLRX
10630
BioLineRX
BLRX
$11.6M
$134K ﹤0.01%
+2,102
New +$116K
CTOS icon
10631
CALL
Custom Truck One Source
CTOS
$2.19B
$134K ﹤0.01%
19,900
-5,800
-23% -$38.2K
ATXS
10632
CALL
DELISTED
Astria Therapeutics
ATXS
$134K ﹤0.01%
16,100
-1,700
-10% -$19.6K
EVM
10633
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
$134K ﹤0.01%
15,057
-1,077
-7% -$9.55K
TERN
10634
CALL
DELISTED
Terns Pharmaceuticals
TERN
$134K ﹤0.01%
+15,300
New +$178K
EPIX
10635
DELISTED
ESSA Pharma
EPIX
$134K ﹤0.01%
+49,530
New +$145K
ESPR
10636
PUT
DELISTED
Esperion Therapeutics
ESPR
$134K ﹤0.01%
96,200
-18,100
-16% -$25.3K
EAD
10637
Allspring Income Opportunities Fund
EAD
$377M
$134K ﹤0.01%
20,714
+10,268
+98% +$64.9K
NOTV
10638
PUT
DELISTED
Inotiv
NOTV
$134K ﹤0.01%
28,000
+100
+0.4% +$552
CVGI icon
10639
CALL
Commercial Vehicle Group
CVGI
$130M
$133K ﹤0.01%
12,000
-22,400
-65% -$203K
KTF
10640
DWS Municipal Income Trust
KTF
$344M
$133K ﹤0.01%
15,454
+3,135
+25% +$27.1K
KOPN icon
10641
Kopin
KOPN
$883M
$133K ﹤0.01%
61,815
-179,541
-74% -$269K
BRDG
10642
CALL
DELISTED
Bridge Investment Group
BRDG
$133K ﹤0.01%
11,700
-31,600
-73% -$322K
PRCH icon
10643
Porch Group
PRCH
$2.01B
$133K ﹤0.01%
96,218
-37,304
-28% -$45.2K
OLMA icon
10644
PUT
Olema Pharmaceuticals
OLMA
$924M
$133K ﹤0.01%
+14,700
New +$88.8K
MOR
10645
DELISTED
MorphoSys AG American Depositary Shares
MOR
$132K ﹤0.01%
+17,713
New +$108K
ROVR
10646
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$132K ﹤0.01%
26,944
-36,932
-58% -$169K
KLRS
10647
PUT
Kalaris Therapeutics
KLRS
$94.5M
$132K ﹤0.01%
+1,691
New +$161K
TEO icon
10648
Telecom Argentina
TEO
$5.66B
$132K ﹤0.01%
21,667
+9,264
+75% +$50.2K
OABI icon
10649
OmniAb
OABI
$653M
$132K ﹤0.01%
26,209
-13,755
-34% -$55.8K
URGN icon
10650
UroGen Pharma
URGN
$2.18B
$132K ﹤0.01%
12,734
-186,699
-94% -$2.06M

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.